Cargando…

PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept

Detalles Bibliográficos
Autores principales: Susic, G, Radunovic, G, Damjanov, N, Novakovic, D, Djurovic, N, Stojanovic, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044150/
http://dx.doi.org/10.1186/1546-0096-11-S2-P156
_version_ 1782319092707885056
author Susic, G
Radunovic, G
Damjanov, N
Novakovic, D
Djurovic, N
Stojanovic, R
author_facet Susic, G
Radunovic, G
Damjanov, N
Novakovic, D
Djurovic, N
Stojanovic, R
author_sort Susic, G
collection PubMed
description
format Online
Article
Text
id pubmed-4044150
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40441502014-06-17 PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept Susic, G Radunovic, G Damjanov, N Novakovic, D Djurovic, N Stojanovic, R Pediatr Rheumatol Online J Poster Presentation BioMed Central 2013-12-05 /pmc/articles/PMC4044150/ http://dx.doi.org/10.1186/1546-0096-11-S2-P156 Text en Copyright © 2013 Susic et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Susic, G
Radunovic, G
Damjanov, N
Novakovic, D
Djurovic, N
Stojanovic, R
PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title_full PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title_fullStr PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title_full_unstemmed PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title_short PReS-FINAL-2144: Bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
title_sort pres-final-2144: bone mineral status in patients with juvenile idiopathic arthritis after 12 months of treatment with etanercept
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044150/
http://dx.doi.org/10.1186/1546-0096-11-S2-P156
work_keys_str_mv AT susicg presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept
AT radunovicg presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept
AT damjanovn presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept
AT novakovicd presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept
AT djurovicn presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept
AT stojanovicr presfinal2144bonemineralstatusinpatientswithjuvenileidiopathicarthritisafter12monthsoftreatmentwithetanercept